Mystery suitor declines to bid for Clarity Commerce
Clarity Commerce Solutions says a potential buyer for its business has declined to make a firm offer.
Clarity Commerce Solutions says a potential buyer for its business has declined to make a firm offer.
Clarity, which produces bespoke software solutions for clients including Debenhams, has been locked in negotiations over a potential sale for several months. Another suitor, Enigmatic has already made two offers, the second values the firm at £10.5m.
Clarity's board believes that Enigmatic's improved offer still undervalues Clarity's prospects but says: "... in the absence of any alternative offer, the Clarity Board considers that each shareholder of the company should consider the improved offer and shareholders are reminded that the improved offer remains open until 1.00 pm on 27 November 2011."
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Despite declining to make a firm offer, the mystery third party has reserved its right to make one in the next six months.
Clarity made a pre-tax loss of £1.435m in the last financial year (to the end of March) and had lost 57% of its value between January and the end of August this year.
The current Enigmatic offer values Clarity at 25p per ordinary share, its price this morning had dropped 1.92% to 25.5p per share.
BS
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Should you invest in biotech?Healthcare and biotech stocks offer tempting valuations following years in the doldrums
-
How to limit how much of your Christmas bonus goes to the taxmanIt's Christmas bonus season but the boosted pay packet may mean much of your hard-earned reward ends up with HMRC instead of in your pocket
